GlassScriptPhysician profile
Laraine Field
NPI 1841406147
$3,878.25
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $462 · 2020: $654 · 2021: $681 · 2022: $438 · 2023: $634 · 2024: $1,009.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,454 · Education: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,454.32 |
| Education | $188.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $787.57 | 2019-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $498.12 | 2019-2024 | |
| Pfizer INC. | $449.47 | 2020-2024 | |
| Astrazeneca Pharmaceuticals LP | $311.98 | 2019-2024 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $311.39 | 2019-2024 | Prolia, Evenity, Repatha |
| Novo Nordisk INC | $279.43 | 2019-2024 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $224.38 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $187.53 | 2020-2022 | |
| Allergan, INC. | $168.90 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $141.46 | 2019-2024 | Verquvo, Steglatro, Belsomra |
| Lilly USA, LLC | $108.69 | 2023-2024 | Mounjaro, Zepbound |
| Abbott Laboratories | $59.60 | 2020-2024 | Freestyle Libre 3 |
| Azurity Pharmaceuticals, INC. | $53.99 | 2023 | Edarbi |
| Sumitomo Pharma America, INC. | $50.09 | 2024 | Gemtesa |
| Mylan Specialty L.P. | $34.06 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.92 | 2021-2022 | |
| Glaxosmithkline, LLC. | $29.13 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $28.32 | 2019 | |
| Boston Scientific Corporation | $23.66 | 2020 | |
| Corium, LLC | $23.44 | 2023 | Azstarys |
| Exact Sciences Corporation | $22.74 | 2023 | Cologuard Collection Kit |
| Alk-Abello, INC | $21.44 | 2024 | Ragwitek, Odactra, Grastek |
| Sanofi Pasteur INC. | $20.93 | 2019 | |
| Endo Pharmaceuticals INC. | $12.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laraine Field listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.